Status:
COMPLETED
Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
National Institute for Medical Research, Tanzania
Ocean Road Cancer Institute, Tanzania
Conditions:
Cervical Cancer
Eligibility:
FEMALE
9+ years
Phase:
PHASE4
Brief Summary
The aims of this study are: 1. To determine feasibility of a school-based human papillomavirus (HPV) vaccination programme in Tanzania. 2. To measure the uptake and acceptability of two different vac...
Detailed Description
Vaccines against human papillomavirus infection, the primary cause of cervical cancer, are an attractive cervical cancer prevention strategy for resource poor settings which lack the infrastructure fo...
Eligibility Criteria
Inclusion
- female pupil
- attends selected school
- born in 1998 if enrolled in school selected for age-based delivery
- attending standard (class) 6 if enrolled in school selected for class-based delivery
Exclusion
- has not previously received HPV vaccine
- has not participated in previous HPV vaccine trials
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
5532 Patients enrolled
Trial Details
Trial ID
NCT01173900
Start Date
August 1 2010
End Date
August 1 2011
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Medical Research
Mwanza, Tanzania